Screener
Solventum SOLV MedSurg — Total Net Sales
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Solventum in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The source filing: Solventum’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 5:27 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001964738-26-000047
| Net Sales (Millions) | Three months ended June 30, 2026 | Three months ended June 30, 2025 | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|---|---|
| Advanced Wound Care | $537 | $467 | $1,034 | $915 |
| Infection Prevention and Surgical Solutions | 836 | 750 | 1,573 | 1,460 |
| MedSurg | 1,372 | 1,218 | 2,607 | 2,375 |
| Dental Solutions | 396 | 338 | 750 | 667 |
| Health Information Systems | 354 | 339 | 696 | 667 |
| Total reportable segment net sales | 2,122 | 1,895 | 4,053 | 3,709 |
| Purification and Filtration | — | 189 | — | 369 |
| All Other | 87 | 77 | 163 | 153 |
Item 1. Financial Statements
FAQ
- What is Solventum's medsurg — total net sales?
- Solventum (SOLV) reported medsurg — total net sales of $1.37B in Q2 2026.
- How has Solventum's medsurg — total net sales changed year-over-year?
- Solventum's medsurg — total net sales increased by 12.6% year-over-year, from $1.22B to $1.37B.
- What is the long-term trend for Solventum's medsurg — total net sales?
- Over 3 years (2022 to 2025), Solventum's medsurg — total net sales has grown at a 1.7% compound annual growth rate (CAGR), from $4.59B to $4.82B.
- What does medsurg — total net sales mean?
- The total revenue generated from the sale of medical-surgical products and services, net of returns, allowances, and discounts. This is the primary indicator of the MedSurg segment's market demand and commercial success.
Ask your AI about Solventum's medsurg — total net sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude